Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2135-2139

  Kramer, Kim ^a   Gerald, William L ^a   Kushner, Brian H ^a   Larson, Steven M ^a   Hameed, Meera ^b   Cheung, Nai Kong V ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GD2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3F8; UNCLASSIFIED DRUG;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOSCINTIGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GANGLIOSIDES; HUMANS; IMMUNOTHERAPY; MALE; NEUROBLASTOMA;

EID: 0031717502     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Joshi, V. V., and Silverman, J. F. Pathology of neuroblastic tumors. Semin. Diag. Pathol., 11: 107-117, 1994.
2. Ambros, I. M., Zellner, A., Roald, B., Amann, G., Ladenstein, R., Printz, D., Gadner, H., and Ambros, P. F. Role of ploidy, chromosome 1p and Schwann cells in the maturation of neuroblastoma. N. Engl. J. Med., 334: 1537-1539, 1996.
3. Franquemont, D. W., Mills, S. E., and Lack, E. E. Immunohistochemical detection of neuroblastomatous foci in composite adrenal-pheochromocytoma-neuroblastoma. Am. J. Clin. Pathol., 102: 163-170, 1994.
4. Hakomori, S. Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Annu. Rev. Biochem., 50: 733-764, 1981.
5. D2 in the immunohistochemical detection and differential diagnosis of neuroblastoma. Am. J. Clin. Pathol., 96: 248-252, 1991.
6. Miraldi, F. D., Nelson, A. D., Kraly, C., Ellery, S., Landmeier, B., Coccia, P. F., Strandjord, S. E., and Cheung, N. K. Diagnostic imaging of human neuroblastoma with radiolabeled antibody. Radiology, 161: 413-418, 1986.
7. Frost, J. D., Hank, J. A., Reaman, G. H., Frierdich, S., Seeger, R. C., Gan, J., Anderson, P. M., Ettinger, L. J., Cairo, M. S., Blazar, B. R., Krailo, M. P., Matthay, K. K., Reisfeld, R. A., and Sondel, P. M. A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14. G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer (Phila.), 80: 317-333, 1997.
8. Cheung, N. K. V. Biological and molecular approaches to diagnosis and treatment. Section I. Principles of immunotherapy. In: P. A. Pizzo and D. G. Poplack (eds.), Principles and Practice of Pediatric Oncology, Ed. 3, pp. 323-342. Philadelphia: J. B. Lippincott Company, 1997.
9. Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V., Castleberry, R. P., DeBernardi, B., Evans, A. E., Favrot, M., and Hedborg, F. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol., 11: 1466-1477, 1993.
10. Yeh, S. D., Larson, S. M., Burch, L., Kushner, B. H., LaQuaglia, M., Finn, R., and Cheung, N. K. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine (MIBG) and standard diagnostic modalities. J. Nucl. Med., 32: 769-776, 1991.
11. Cheung, N. K., Heller, G., Kushner, B. H., Liu, C., and Cheung, I. Y. Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive? J. Clin. Oncol., 15: 2807-2817, 1997.
12. Brodeur, G. M., and Castleberry, R. P. Neuroblastoma. In: D. G. Poplack and P. A. Pizzo (eds.), Principles of Oncology, pp. 761-797. Philadelphia: J. B. Lippincott Co., 1997.
13. Cheung, N. K., Kushner, B. H., LaQuaglia, M., and Lindsley, K. Treatment of advanced stage neuroblastoma. In: D. Reghavan, H. I. Scher, S. A. Leibel, and P. Lange (eds.), Principles and Practice of Genitourinary Oncology, pp. 1101-1111. Philadelphia: J. B. Lippincott Company, 1997.
14. Tsokos, M., Scarpa, S., Ross, R. A., and Triche, T. J. Differentiation of human neuroblastoma recapitulates neural crest development. Am. J. Pathol., 128: 484-496, 1987.
15. Wahl, H. R. Neuroblastomata. With a study of case illustrating the three types that arise from the sympathetic system. J. Med. Res., 30: 205, 1914.
16. Wahl, H. R., and Robinson, D. Neuroblastoma of the mediastinum with pheochromoblastomatous elements. Arch. Pathol., 35: 571-578, 1943.
17. Cooper, M. J., Hutchins, M., Cohen, P. S., Helman, L. J., Mennie, R. J., and Israel, M. A. Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ., 1: 149-159, 1990.
18. Lopez-Andreu, J. A., Castel, V., Verdeguer, A., Muro, M. D., Esquembre, C., and Ferris, J. Neuroblastoma IV-S followed by extra-adrenal pheochromocytoma 15 years later. Med. Pediat. Oncol., 24: 388-391, 1995.
19. Helson, L., Grabstald, H., and Huvos, A. G. Neuroblastoma. Observations on long-term survivors. Clin. Bull. Mem. Sloan-Kettering Cancer Cent., 3: 3-9, 1973.
20. Jager, E., Ringhoffer, M., Karbach, J., Arand, M., Oesch, F., and Knath, A. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Int. J. Cancer, 66: 470-476, 1996.
21. Kwak, L. W., Grossbard, M. L., and Urba, W. J. B-cell lymphomas. In: V. T. J. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Biologic Therapy of Cancer, Ed. 2, pp. 553-565. Philadelphia: J. B. Lippincott, 1995.